Susan P. Etheridge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susan P. Etheridge has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Elizabeth V. Saarel
Division of Pediatric Cardiology, University of Utah, Salt Lake City, Utah
2 shared publicationsAlan Rope
Division of Medical Genetics, University of Utah, Salt Lake City, Utah
1 shared publicationArthur A.M. Wilde
Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
1 shared publicationCHRISTOPHER J. McGANN
University of Utah School of Medicine, Salt Lake City, Utah, USA
1 shared publicationCammon B. Arrington
Division of Pediatric Cardiology, University of Utah, Salt Lake City, Utah
1 shared publicationCecilia A. Albaro
University of Utah, Salt Lake City, Utah
1 shared publication
Latest Publications
- 9 September 2011
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (10) , 2578-2583
Somatic mosaicism contributes to phenotypic variation in Timothy syndrome
Timothy syndrome type 1 (TS‐1) is a rare disorder that affects multiple organ systems and has a high incidence of sudden death due to profound QT prolongation and resultant ventricular arrhythmias. All previously described cases of TS‐1 are the result of a missense mutation in exon 8A (p.G406R), an alternatively spliced variant of the L‐type calcium channel gene (Cav1.2, CACNA1C). Most patients reported in the literature represent highly affected individuals who present early in life with severe cardiac and neurological manifestations. Here, we describe somatic mosaicism in TS‐1 patients with less severe manifestations than the typical TS‐1 patient. These findings suggest that the TS prognosis may not be as dismal as previously reported. Moreover, our findings have implications for genetic counseling in that previously described de novo TS mutations may represent cases of parental mosaicism and warrant careful genotyping of parental tissue other than peripheral blood lymphocytes.
- 9 September 2011
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (10) , 2578-2583
Somatic mosaicism contributes to phenotypic variation in Timothy syndrome
Timothy syndrome type 1 (TS‐1) is a rare disorder that affects multiple organ systems and has a high incidence of sudden death due to profound QT prolongation and resultant ventricular arrhythmias. All previously described cases of TS‐1 are the result of a missense mutation in exon 8A (p.G406R), an alternatively spliced variant of the L‐type calcium channel gene (Cav1.2, CACNA1C). Most patients reported in the literature represent highly affected individuals who present early in life with severe cardiac and neurological manifestations. Here, we describe somatic mosaicism in TS‐1 patients with less severe manifestations than the typical TS‐1 patient. These findings suggest that the TS prognosis may not be as dismal as previously reported. Moreover, our findings have implications for genetic counseling in that previously described de novo TS mutations may represent cases of parental mosaicism and warrant careful genotyping of parental tissue other than peripheral blood lymphocytes.
- 23 March 2004
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 15 (3) , 371
Arrhythmogenic Right Ventricular Cardiomyopathy Without Fatty Infiltration
- 23 March 2004
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 15 (3) , 371
Arrhythmogenic Right Ventricular Cardiomyopathy Without Fatty Infiltration
- 1 June 2003
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (12) , 1497-1500
QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure
- 1 June 2003
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (12) , 1497-1500
QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure
- 12 June 2001
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 13 (1) , 11-24
Radiofrequency catheter ablation of left-sided accessory pathways in pediatric patients
- 12 June 2001
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 13 (1) , 11-24
Radiofrequency catheter ablation of left-sided accessory pathways in pediatric patients
- Open Access
- 1 March 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 71 (3) , 1016-1018
An unusual cause of severe cyanosis in infancy
- 1 March 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 71 (3) , 1016-1018
Open AccessAn unusual cause of severe cyanosis in infancy
- 1 January 2001
- Published by Elsevier in American Heart Journal
- Vol. 141 (1) , 105-110
Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants
- 1 January 2001
- Published by Elsevier in American Heart Journal
- Vol. 141 (1) , 105-110
Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants